Conference abstractPublished 29 Jun 2017
Released-active antibodies are innovative products for the effective management of severe respiratory viral infections
The Institute of General Pathology and Pathophysiology, Russia; Materia Medica Holding, Russia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Viral respiratory infections represent one of the main threats to human health. Antibodies-based therapy is a modern trend for combating viral infections, restricted by challenging administration and manufacturing. Our entirely new approach is to use antibodies (Abs) to immune regulators in a specific technological form, capable of surmounting these drawbacks. We found that after the initial Abs substance gradual consequent concentrationâÂ?Â? decrease a specific activity releases (released-activity- RA) which is not to directly neutralize the target, but to modify it, e.g., RA Abs to IFNÃ?³ and RA Abs to CD4 stimulate non-specific and specific immunity, while RA Abs to histamine influence anti-inflammatory network. These AbsâÂ?Â? use demonstrated efficacy in experimental studies of major viral respiratory infections. Methodology & Theoretical Orientation: RA Abs to IFNÃ?³ were evaluated by using standard models of influenza A/H1N1pdm09 (Oseltamivir resistant and sensitive strain), MERS-HCoV and RSV/Long infections in vitro; and in complex with RA Abs to histamine and RA Abs to CD4 against influenza A/H3N2 infection in vivo. Findings: RA Abs have shown anti-influenza effect against its seasonal and pandemic strains, 2 times increasing the survival, and 10 times lowering virus titer (p 100 times vs. Oseltamivir alone (p 1000 times, p<0.05) virus titer decrease was found. Conclusion & Significance: our fundamentally new approach to AbsâÂ?Â? therapeutic use not only offers an opportunity to safely and effectively treat a wide spectrum of infections even the most dangerous, but also to increase the existing drugsâÂ?Â? efficacy via their conjoin application with RA Abs.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Emelyanova A G”
- BylineArticles whose byline prints “Petrova N V”
- BylineArticles whose byline prints “Nikiforova N V”
- BylineArticles whose byline prints “Kanareikina M A”
- BylineArticles whose byline prints “Yakovleva N N”
- BylineArticles whose byline prints “Gorbunov E A”
- BylineArticles whose byline prints “Tarasov S A”
